PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24138479 ↗2013Reported benefit

Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury

MouseSpinal cord injuryUnspecifiedC57BL/6Subacute phase of secondary injury; exact administration time not stated

Model: Experimental spinal cord injury in a mouse model, with in vitro and in vivo assessment of the subacute phase of secondary injury

Minocycline loaded nanoparticles reduced activation and proliferation of microglia and macrophages around the lesion site, shifted cells from a round phagocytic-like phenotype towards an arborised resting-like phenotype with low CD68 staining, and reduced proinflammatory IL-6 expression with persis…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.